V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20153571 | 20157936 | 1.57 | 81.2 | null | 2021-12-03 | 2022-02-12 | Rituximab | 02 | null | HEPATOBLASTOMA RELAPSE VI | 101299683 |
| 20153599 | 20157937 | 1.71 | 61.5 | null | 2016-06-20 | 2016-07-13 | Nintedanib | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101454725 |
| 20154024 | 20157938 | 1.75 | 64.6 | Palliative (P) | 2020-01-16 | 2020-01-31 | NAB PACLITAXEL | 1 | null | EXEMESTANE + PALBOCICLIB | 101388079 |
| 20154032 | 20157939 | 1.65 | 44.9 | null | 2021-10-09 | 2022-02-02 | Fluorouracil + Streptozocin | 02 | N | MITOMYCIN | 100813637 |
| 20154246 | 20157940 | 1.65 | 61.2 | Palliative (P) | 2019-06-07 | 2020-02-10 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100290184 |
| 20154366 | 20157941 | 1.79 | 71.15 | Curative (C) | 2019-02-14 | 2019-07-05 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | null | TEMOZOLOMIDE | 101140001 |
| 20154448 | 20157942 | 1.8 | 70 | null | 2018-02-19 | 2018-02-19 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | null | IDELALISIB | 100917844 |
| 20154494 | 20157943 | 1.72 | 69.8 | null | 2021-02-16 | 2021-03-19 | Capecitabine + Streptozocin | 02 | null | DERAZANTINIB | 100960279 |
| 20154786 | 20157944 | null | 69 | null | 2018-03-22 | 2018-03-22 | CAV | 02 | N | COSMIC TRIAL | 100122535 |
| 20154805 | 20157945 | 1.5 | 71 | Palliative (P) | 2020-02-13 | 2020-02-22 | Cisplatin 100 + RT(H&N) 1 day | 02 | null | CARBOPLATIN + PEMETREXED | 101820297 |
| 20155154 | 20157946 | 1.6 | 0 | null | 2018-10-23 | 2018-11-25 | CAPECITABINE + OXALIPLATIN + RT | 2 | null | IBRUTINIB | 100514947 |
| 20155405 | 20157947 | 1.8 | 72.3 | null | 2017-06-17 | 2017-06-29 | null | 02 | null | GEMCITABINE + OXALIPLATIN | 101251792 |
| 20155475 | 20157948 | 1.8 | 61 | Palliative (P) | 2018-04-28 | 2018-05-14 | NEO-AEGIS TRIAL | 02 | N | CARBOPLATIN + VINORELBINE | 101204404 |
| 20155704 | 20157950 | 1.69 | 90 | Curative (C) | 2018-04-10 | 2018-11-16 | BCG Intravesical | 02 | Y | NEO-AEGIS TRIAL | 101430895 |
| 20155759 | 20157951 | 0 | 17.2 | Adjuvant (A) | 2019-12-20 | 2019-12-24 | PHITT D2 Carboplatin / etoposide | 02 | N | LAROTRECTINIB | 101793421 |
| 20156052 | 20157954 | 1.69 | null | Palliative (P) | 2018-08-13 | 2018-08-13 | Gemcitabine + RT pancreas | 02 | N | CAPECITABINE + STREPTOZOCIN | 100769542 |
| 20156098 | 20157955 | 0 | 18.5 | Palliative (P) | null | 2021-05-10 | Carboplatin + Pemetrexed | 02 | N | BCG | 101321781 |
| 20156982 | 20157957 | 0 | 14.8 | Palliative (P) | null | 2019-04-02 | EEF or EOF | 99 | N | CAPECITABINE + DOCETAXEL | 101543008 |
| 20157011 | 20157958 | 1.6 | 81.1 | Palliative (P) | 2018-08-19 | 2018-08-20 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | N | AFLIBERCEPT + FLUOROURACIL + IRINOTECAN | 101120671 |
| 20157177 | 20157959 | null | null | Neo-adjuvant (N) | 2020-01-14 | 2020-07-29 | Cyclophosphamide Weekly PO | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101243634 |
| 20157247 | 20157960 | 1.71 | 106 | null | 2020-10-12 | 2020-11-02 | CISPLATIN + RALTITREXED | 02 | N | CISPLATIN + PEMETREXED | 101484743 |
| 20157251 | 20157961 | 1.48 | 62.2 | Palliative (P) | 2015-10-22 | 2016-05-17 | TOPOTECAN | 2 | N | COSMIC TRIAL | 100624380 |
| 20157513 | 20157963 | 1.51 | 12.3 | null | null | 2020-01-24 | GemCarbo Days 1+8 | null | Y | DABRAFENIB + TRAMETINIB | 100089083 |
| 20157596 | 20157964 | 1.83 | null | Palliative (P) | 2017-12-10 | 2017-12-30 | Cyclophosphamide High Dose | 02 | N | NEO-AEGIS TRIAL | 100080821 |
| 20158038 | 20157965 | 1.85 | 55.4 | Adjuvant (A) | 2019-07-12 | 2019-07-12 | Fulvestrant + Palbociclib | N | N | CYCLOPHOSPHAMIDE + POMALIDOMIDE | 101558055 |
| 20158509 | 20157966 | 1.71 | 75.6 | null | 2019-05-07 | 2019-09-16 | null | 02 | null | IPILIMUMAB | 100658098 |
| 20158621 | 20157967 | 1.87 | 33.85 | Palliative (P) | null | 2020-01-26 | Hydroxycarbamide | Y | N | CARBOPLATIN + PEMETREXED | 101435620 |
| 20158965 | 20157968 | 1.75 | 86.6 | null | 2018-08-06 | 2018-08-06 | ECF | null | Y | CISPLATIN + VINORELBINE | 101443493 |
| 20159094 | 20157969 | 1.58 | 79.5 | null | 2019-08-22 | 2019-08-22 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | ARISTOTLE TRIAL | 101121232 |
| 20159169 | 20157970 | 1.62 | 38.95 | Curative (C) | 2017-12-06 | 2017-12-11 | Durvalumab | 01 | N | FULVESTRANT + RIBOCICLIB | 100933100 |
| 20159217 | 20157971 | 1.72 | 86.1 | null | 2021-11-19 | 2021-11-24 | ARISTOTLE TRIAL | 02 | null | ECARBOX | 100609557 |
| 20159318 | 20157972 | 1.84 | 58 | Curative (C) | 2016-06-14 | 2016-06-14 | ECarboX | N | null | FOXTROT TRIAL | 101398261 |
| 20159370 | 20157974 | 1.57 | 81.9 | Neo-adjuvant (N) | null | 2020-11-20 | BCG Intravesical | null | N | CISPLATIN + VINORELBINE | 101429125 |
| 20159702 | 20157977 | 1.84 | 64.9 | null | 2018-06-05 | 2018-06-07 | GEFITINIB | 01 | null | CISPLATIN + VINORELBINE | 100838496 |
| 20159997 | 20157978 | 1.8 | null | Palliative (P) | 2018-07-20 | 2018-07-31 | FOCUS4 TRIAL | 02 | N | CYTARABINE | 100350157 |
| 20160123 | 20157979 | 1.81 | 77 | Curative (C) | 2018-12-11 | 2019-02-26 | CAV | 02 | null | ESPAC TRIAL | 100490191 |
| 20160321 | 20157980 | 1.57 | 69.5 | null | 2019-06-19 | 2019-06-26 | ACTICCA-1 Trial | 02 | null | CAPECITABINE + STREPTOZOCIN | 101866424 |
| 20160629 | 20157981 | 1.53 | 86.6 | Curative (C) | 2020-08-06 | 2020-08-15 | Hepatoblastoma HR Carbo/Dox | 02 | null | CARBOPLATIN + VINORELBINE | 101802734 |
| 20161010 | 20157983 | 1.51 | 58.9 | null | 2018-12-27 | 2019-01-01 | null | 02 | null | OXALIPLATIN + MDG + PANITUMUMAB | 100243890 |
| 20161356 | 20157984 | 1.52 | 72.6 | null | 2017-05-05 | 2017-05-07 | Temozolomide 150mg/m2 | 02 | N | BALLAD TRIAL | 100087950 |
| 20162528 | 20157987 | 1.57 | 83.1 | Adjuvant (A) | 2016-11-15 | 2019-08-05 | LOMUSTINE + MDG | 2 | N | AZACITIDINE | 101312819 |
| 20163720 | 20157990 | 1.56 | 54.5 | Palliative (P) | 2018-06-24 | 2018-07-02 | Azacitidine | 02 | N | CISPLATIN + RALTITREXED | 100483954 |
| 20163753 | 20157991 | 0 | 0 | Palliative (P) | 2019-11-19 | 2019-11-22 | GO2 TRIAL | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100060253 |
| 20164336 | 20157992 | 1.53 | 101.8 | 03 | 2018-07-30 | 2018-08-26 | COSMIC TRIAL | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 101712263 |
| 20166559 | 20157994 | 1.61 | 87.8 | Curative (C) | 2018-04-06 | 2018-10-29 | DOCETAXEL + GEMCITABINE | 02 | null | TCX | 100036528 |
| 20166977 | 20157995 | 1.83 | 53.8 | Palliative (P) | 2020-01-15 | 2020-04-01 | AXITINIB | 02 | N | BORTEZOMIB + PANOBINOSTAT | 101172167 |
| 20167074 | 20157996 | null | null | Palliative (P) | 2021-09-12 | 2021-11-01 | Rituximab (Maintenance) | 02 | N | AZACITIDINE | 100949572 |
| 20167281 | 20157997 | 1.19 | 55 | Palliative (P) | 2017-05-27 | 2017-07-31 | STS Non-Rhabdo EpSSG 2005 Vcy | 2 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101265092 |
| 20167598 | 20157998 | null | 94.5 | null | 2021-07-28 | 2022-02-05 | CARBOPLATIN + VINORELBINE | 02 | null | GEMCITABINE + OXALIPLATIN | 100419704 |
| 20167655 | 20157999 | 1.58 | 68 | 03 | 2019-08-06 | 2019-08-13 | FOCUS4 TRIAL | 02 | N | NB TEMOZOLOMIDE | 100695041 |